Valeant Pharmaceuticals International (VRX)

Add to Watchlists Create an Alert
74.67 -0.15  -0.20%   NYSE May 23, 8:00PM BATS Real time Currency in USD

Valeant Pharmaceuticals International Cash from Financing Quarterly:

-515.92M for March 31, 2013
View Full Chart

Valeant Pharmaceuticals International Cash from Financing Quarterly Chart

    Valeant Pharmaceuticals International Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -515.92M
    Dec. 31, 2012 2.562B
    Sept. 30, 2012 -7.932M
    June 30, 2012 292.50M
    March 31, 2012 210.44M
    Dec. 31, 2011 1.237B
    Sept. 30, 2011 299.02M
    June 30, 2011 -330.17M
    March 31, 2011 742.77M
    Dec. 31, 2010 -164.49M
    Sept. 30, 2010 -10.59M
    June 30, 2010 -25.50M
    March 31, 2010 -12.70M
    Dec. 31, 2009 -68.43M
    Sept. 30, 2009 -89.21M
    June 30, 2009 394.02M
    March 31, 2009 -59.33M
    Dec. 31, 2008 -4.304M
    Sept. 30, 2008 -59.55M
    June 30, 2008 -146.32M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    VRX Cash from Financing Quarterly Benchmarks

    Companies
    Actavis -42.50M
    Mylan 6.599M
    Warner Chilcott -290.00M

    VRX Cash from Financing Quarterly Rankings

    Overall 45th percentile
    4350 of 8006
    Sector 23rd percentile
    526 of 686 in Healthcare
    Industry 20th percentile
    54 of 68 in Drug Manufacturers - Specialty & Generic

    VRX Cash from Financing Quarterly Range, Past 5 Years

    Minimum -515.92M Mar 2013
    Maximum 2.562B Dec 2012
    Average 212.16M